Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Maikang Biotechnology is a Chinese medical technology company specializing in the development and commercialization of in vitro diagnostic (IVD) solutions. Based in Shanghai's Zhangjiang Hi-Tech Park, the company focuses on point-of-care testing (POCT) platforms that utilize advanced fluorescence immunoassay and chemiluminescence technologies. Its product portfolio includes a variety of rapid diagnostic kits for cardiovascular markers, inflammatory indicators, and infectious diseases, alongside automated analytical instruments. Maikang Bio's systems are designed for use in emergency departments, intensive care units, and clinical laboratories to facilitate timely medical decision-making. The company maintains rigorous quality standards, including ISO 13485 certification, to support its domestic and international market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Maikang BioTech.